IXensor Co., Ltd.
6734
Rank in Stocks
#29839
iXensor Co., Ltd. operates a cutting-edge technological platform that... iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest Blood Glucose Monitoring System and PixoTest POCT System assist in managing long-term conditions. Women's Health: The Eveline Smart Fertility System and Eveline Care Telehealth Platform provide tools for fertility tracking and remote care. Infectious Diseases: Offerings such as the PixoTest COVID-19 Rapid Antigen Test facilitate rapid detection and management. Additionally, iXensor provides supporting digital infrastructure, including the PixoHealth Pass Admin app and its corresponding web portal. Established in Taipei, Taiwan, in 2012, the company is a pioneer in mobile-driven diagnostic solutions.
Share Price
$0.16004341
Last synced: 2026-11-10
Market Cap
$6.73M
Change (1 day)
0.96%
Change (1 year)
-30.14%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade IXensor Co., Ltd. (6734)
Category
Healthcare
Operating Margin for IXensor Co., Ltd. (6734)
Operating Margin as of November 2026 TTM: -181.30%
According to IXensor Co., Ltd.'s latest financial reports, its current operating margin (TTM) is -181.30%. At the end of 2025 the company had an operating margin of -170.06%.
Operating Margin history for IXensor Co., Ltd. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -181.30% | 6.61% |
| 2025 | -170.06% | -28.19% |
| 2024 | -236.83% | -21.52% |
| 2023 | -301.77% | 5,971.83% |
| 2022 | -4.97% | -98.49% |
| 2021 | -328.63% | -34.61% |
| 2020 | -502.56% | 38.42% |
| 2019 | -363.07% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.08% |
US
|
|
| 18.08% | -100.10% |
IE
|
|
| 21.25% | -100.12% |
US
|
|
| 21.05% | -100.12% |
US
|
|
| 28.09% | -100.15% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about IXensor Co., Ltd.'s operating margin
What is IXensor Co., Ltd.'s operating margin?
IXensor Co., Ltd.'s operating margin is -181.30%, as of Nov 2026.
What was IXensor Co., Ltd.'s operating margin in 2025?
In 2025, IXensor Co., Ltd.'s operating margin was -170.06%, compared with -236.83% in 2024.
How has IXensor Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, IXensor Co., Ltd.'s operating margin was highest in 2022 (-4.97%) and lowest in 2020 (-502.56%).
How does IXensor Co., Ltd.'s operating margin compare with similar companies?
IXensor Co., Ltd.'s operating margin (-181.30%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.